Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 21, 2020 - Issue 3
Submit an article Journal homepage
1,388
Views
28
CrossRef citations to date
0
Altmetric
Drug Evaluation

An evaluation of liraglutide including its efficacy and safety for the treatment of obesity

Chen-Hsiu LinDivision of Cardiology, Department of Internal Medicine, Taipei Medical University, Taipei, TaiwanView further author information
,
Li ShaoThe VIP Department, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Yu-Mei ZhangThe VIP Department, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Yu-Ju TuThe VIP Department, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaView further author information
,
Yuzhen ZhangResearch Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai, ChinaORCID Iconhttps://orcid.org/0000-0002-9570-1269View further author information
ORCID Icon,
Brian TomlinsonResearch Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine, Shanghai, China;Faculty of Medicine, Macau University of Science and Technology, Taipa, MacauORCID Iconhttps://orcid.org/0000-0001-6717-5444View further author information
ORCID Icon,
Paul ChanDivision of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, TaiwanCorrespondence[email protected]
View further author information
&
Zhongmin LiuDepartment of Cardiac Surgery, Shanghai East Hospital, Tongji University, Shanghai, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 275-285 | Received 12 Aug 2019, Accepted 18 Nov 2019, Published online: 02 Dec 2019

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jae Geun Song, Da Hyun Kim & Hyo-Kyung Han. (2023) Fabrication and Evaluation of a pH-Responsive Nanocomposite-Based Colonic Delivery System for Improving the Oral Efficacy of Liraglutide. International Journal of Nanomedicine 18, pages 3937-3949.
Read now
Ozge Telci Caklili, Mustafa Cesur, Dimitri P Mikhailidis & Manfredi Rizzo. (2023) Novel Anti-obesity Therapies and their Different Effects and Safety Profiles: A Critical Overview. Diabetes, Metabolic Syndrome and Obesity 16, pages 1767-1774.
Read now
Jonathan Flintoff, James P Kesby, Dan Siskind & Thomas HJ Burne. (2021) Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential. Expert Opinion on Investigational Drugs 30:8, pages 877-891.
Read now
Xue Lv, Kun Fang, Wenqing Hao, Yuxin Han, Nailong Yang & Qing Yu. (2020) Identification of Reactive Hypoglycemia with Different Basic BMI and Its Causes by Prolonged Oral Glucose Tolerance Test. Diabetes, Metabolic Syndrome and Obesity 13, pages 4717-4726.
Read now

Articles from other publishers (24)

Simon Kloock, Christian G. Ziegler & Ulrich Dischinger. (2023) Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?. Pharmacology & Therapeutics 251, pages 108549.
Crossref
Xintian Shou, Yumeng Wang, Chenglin Duan, Guozhen Yuan, Namin Wei, Yihan Yang & Yuanhui Hu. (2023) Knowledge Domain and Emerging Trends of Glucagon-Like Peptide 1 Receptor Agonists in Cardiovascular Research: A Bibliometric Analysis. Current Problems in Cardiology 48:8, pages 101194.
Crossref
Mihaela-Simona Popoviciu, Lorena Păduraru, Galal Yahya, Kamel Metwally & Simona Cavalu. (2023) Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials. International Journal of Molecular Sciences 24:13, pages 10449.
Crossref
Yaochen Xie, Qian Zhou, Qiaojun He, Xiaoyi Wang & Jincheng Wang. (2023) Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition. Acta Pharmaceutica Sinica B 13:6, pages 2383-2402.
Crossref
Cristina Bouzas, Rosario Pastor, Silvia Garcia, Margalida Monserrat-Mesquida, Miguel Ángel Martínez-González, Jordi Salas-Salvadó, Dolores Corella, Albert Goday, J. Alfredo Martínez, Ángel M. Alonso-Gómez, Olga Fernández-Barceló, Jesús Vioque, Dora Romaguera, José Lopez-Miranda, Ramón Estruch, Francisco J. Tinahones, José Lapetra, Lluís Serra-Majem, Blanca Riquelme-Gallego, Vicente Martín-Sánchez, Xavier Pintó, Miguel Delgado-Rodriguez, Pilar Matía, Josep Vidal, Jersy-Jair Cardenas-Salas, Lidia Daimiel, Emilio Ros, Estefanía Toledo, Josep M. Manzanares, Inmaculada Gonzalez-Monge, Miguel-Ángel Muñoz, Diego Martinez-Urbistondo, Lucas Tojal-Sierra, Carlos Muñoz-Bravo, Salvador Miralles-Gisbert, Marian Martin, Antonio García-Ríos, Sara Castro-Barquero, José Carlos Fernández-García, José Manuel Santos-Lozano, F. Javier Basterra-Gortari, Liliana Gutiérrez-Carrasquilla, Patricia Guillem-Saiz, Alba Satorres, Itziar Abete, Carolina Sorto-Sanchez, Javier Díez-Espino, Nancy Babio, Montse Fitó & Josep A. Tur. (2023) Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome. Biomedicine & Pharmacotherapy 161, pages 114561.
Crossref
Ramin Abdi Dezfouli, Ali Hosseinpour, Mostafa Qorbani & Elnaz Daneshzad. (2023) The efficacy of topical aminophylline in local fat reduction: A systematic review. Frontiers in Endocrinology 14.
Crossref
Amin Gasmi, Pavan Kumar Mujawdiya, Amine Nehaoua, Mariia Shanaida, Yuliya Semenova, Salva Piscopo, Alain Menzel, Volodymyr Voloshyn, Olena Voloshyn, Volodymyr Shanaida & Geir Bjørklund. (2023) Pharmacological Treatments and Natural Biocompounds in Weight Management. Pharmaceuticals 16:2, pages 212.
Crossref
Alejandra Cornejo-Estrada, Carlos Nieto-Rodríguez, Darwin A. León-Figueroa, Emilly Moreno-Ramos, Cielo Cabanillas-Ramirez & Joshuan J. Barboza. (2023) Efficacy of Liraglutide in Obesity in Children and Adolescents: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Children 10:2, pages 208.
Crossref
Suzanne Cuda, Marisa Censani, Roohi Kharofa, Valerie O'Hara, Rushika Conroy, Dominique R. Williams, Jennifer Paisley, Allen F. Browne, Sara Karjoo & Nancy T. Browne. (2022) Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022. Obesity Pillars 4, pages 100048.
Crossref
Xiong Wang, Yanhua Zhang, Lei Zhang, Wenli Wang, Huilian Che & Yali Zhang. (2022) Piperine attenuates hepatic steatosis and insulin resistance in high-fat diet-induced obesity in Sprague-Dawley rats. Nutrition Research 108, pages 9-21.
Crossref
Dan Xu, Ankith Nair, Charlie Sigston, Chau Ho, Jia Li, Daya Yang, Xinxue Liao, Wei Chen, Ming Kuang, Yanbing Li, Christopher Reid & Haipeng Xiao. (2022) Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations. Cardiovascular Therapeutics 2022, pages 1-9.
Crossref
Abhinav Sinha, Parul Puri & Sanghamitra Pati. (2022) Social determinants of diabesity and its association with multimorbidity among older adults in India: a population-based cross-sectional study. BMJ Open 12:11, pages e061154.
Crossref
Yanxin Xiao, Yan LiuLiwei ZhaoYaru Zhou. (2022) Effect of 5:2 Fasting Diet on Liver Fat Content in Patients with Type 2 Diabetic with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 20:8, pages 459-465.
Crossref
Eva Madrid, Miranda Ocara Vargas, Catalina Contreras-Vera, Cristina Saldías, Camila Micaela Escobar Liquitay, Victoria Novik A, Sergio R Munoz & Javier Bracchiglione. (2022) Glucagon-like peptide-1 analogues for overweight or obese adults. Cochrane Database of Systematic Reviews 2022:9.
Crossref
Rachel Agius, Claudia Coelho & Barbara McGowan. (2022) GLP-1 analogues in clinical management of obesity. Current Opinion in Endocrine and Metabolic Research 25, pages 100360.
Crossref
Sumaiah J. Alarfaj, Alnada Ibrahim, Jawaher Alshahrani, Modhi Alnuwaysir, Atlal Almutairi & Basmah Alwahhabi. (2022) Effectiveness, tolerability, and pattern of liraglutide treatment use for weight loss: a mixed-methods cohort study. Journal Of Advanced Pharmacy Education And Research 12:2, pages 63-70.
Crossref
Xiaorui Lyu, Kemin Yan, Xin Wang, Hanyuan Xu, Xiaonan Guo, Huijuan Zhu, Hui Pan, Linjie Wang, Hongbo Yang & Fengying Gong. (2022) A novel anti-obesity mechanism for liraglutide by improving adipose tissue leptin resistance in high-fat diet-fed obese mice. Endocrine Journal 69:10, pages 1233-1244.
Crossref
Carolina Sensi, Valdo Ricca, Shaun Gravestock & Marco O. Bertelli. 2022. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder. Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder 655 684 .
Luis D'Marco, Valery Morillo, José Luis Gorriz, María K. Suarez, Manuel Nava, Ángel Ortega, Heliana Parra, Nelson Villasmil, Joselyn Rojas-Quintero & Valmore Bermúdez. (2021) SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence. Journal of Diabetes Research 2021, pages 1-17.
Crossref
Nick Finer. (2021) Future directions in obesity pharmacotherapy. European Journal of Internal Medicine 93, pages 13-20.
Crossref
Anna M. FORMENTI. (2021) Obesity: towards a personalized management of a disease with severe clinical implication. Minerva Endocrinology 46:2.
Crossref
Zhuohui Luo, Jiawen Huang, Zhiping Li, Zhiwen Liu, Linchun Fu, Yingjie Hu & Xiaoling Shen. (2021) Cajanolactone A, a Stilbenoid From Cajanus canjan (L.) Millsp, Prevents High-Fat Diet-Induced Obesity via Suppressing Energy Intake. Frontiers in Pharmacology 12.
Crossref
Anca Pantea Stoian, Nikolaos Papanas, Martin Prazny, Ali A. Rizvi & Manfredi Rizzo. (2020) Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. Journal of Cardiovascular Pharmacology and Therapeutics 25:6, pages 494-496.
Crossref
Roya Kelishadi. (2020) Liraglutide for management of adolescent obesity. Nature Reviews Endocrinology 16:8, pages 405-406.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.